pl

Zarejestruj się
Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów.

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Strona główna・Stock List・BioNTech SE ADR
Search

BioNTech SE ADR

Closed

Sector Healthcare

89.58 -0.49

Buy

Price update 6 wrz 2024, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

88.71

Max

90.18

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+20.24 upside

Dividends

By Dow Jones

Next Earnings

4 lis 2024

News Sentiment

By Acuity

50%

50%

114 / 365 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

88.19 / 90.24 Support & Resistance

BioNTech SE ADR Chart

Related News

6 maj 2024, 11:27 UTC

Earnings

BioNTech Swings to Net Loss on Lower Covid Vaccine Sales

DJ

Read

20 mar 2024, 10:44 UTC

Earnings

BioNTech Profit Slumps on Lower Covid Vaccine Sales

DJ

Read

8 lut 2024, 11:43 UTC

Acquisitions, Mergers, Takeovers

BioNTech Agrees To Invest $200 Million in Autolus, Starts Strategic Collaboration

DJ

Read

5 sie 2024, 10:02 UTC

Earnings

BioNTech Sees 2024 R&D Expenses EUR2.4B-EUR2.6B >BNTX

DJ

Read

5 sie 2024, 10:01 UTC

Earnings

BioNTech Backs 2024 View of Rev EUR2.5B-EUR3.1B >BNTX

DJ

Read

5 sie 2024, 10:01 UTC

Earnings

BioNTech: Invested EUR525.6M, or About 90% of 2Q R&D Spend, in Non-Covid-19 Related Activities >BNTX

DJ

Read

5 sie 2024, 10:00 UTC

Earnings

BioNTech 2Q-End Cash, Equivalents, Security Investments EUR18.5 Billion >BNTX

DJ

Read

5 sie 2024, 09:59 UTC

Earnings

BioNTech 2Q Loss EUR807.8M >BNTX

DJ

Read

5 sie 2024, 09:59 UTC

Earnings

BioNTech 2Q Loss/Shr EUR3.36 >BNTX

DJ

Read

5 sie 2024, 09:59 UTC

Earnings

BioNTech 2Q Rev EUR128.7M >BNTX

DJ

Read

6 maj 2024, 20:15 UTC

Earnings

BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come -- IBD

DJ

Read

6 maj 2024, 10:47 UTC

Earnings

BioNTech Sees FY24 Rev EUR2.5B-EUR3.1B >BNTX

DJ

Read

6 maj 2024, 10:46 UTC

Earnings

Correct: BioNTech 1Q Loss/Shr EUR1.31 >BNTX

DJ

Read

6 maj 2024, 10:46 UTC

Earnings

Correct: BioNTech 1Q Loss EUR315.1M >BNTX

DJ

Read

6 maj 2024, 10:46 UTC

Earnings

Correct: BioNTech 1Q Rev EUR187.6M >BNTX

DJ

Read

6 maj 2024, 10:45 UTC

Earnings

BioNTech 1Q Rev $187.6M >BNTX

DJ

Read

6 maj 2024, 10:45 UTC

Earnings

BioNTech 1Q Loss $315.1M >BNTX

DJ

Read

6 maj 2024, 10:45 UTC

Earnings

BioNTech 1Q Loss/Shr $1.31 >BNTX

DJ

Read

26 mar 2024, 05:00 UTC

Earnings

This Vaccine Maker Sits on Cash Almost Equal to Its Market Value -- Barrons.com

DJ

Read

20 mar 2024, 11:44 UTC

Earnings

BioNTech Earnings Fall Short of Estimates. The Stock Is Down. -- Barrons.com

DJ

Read

20 mar 2024, 10:27 UTC

Earnings

BioNTech's Stock Sinks After Earnings Fall Below Expectations, Hurt By Writedowns Of Vaccine Inventory -- MarketWatch

DJ

Read

20 mar 2024, 10:17 UTC

Earnings

BioNTech 4Q Rev EUR1.48B >BNTX

DJ

Read

20 mar 2024, 10:15 UTC

Earnings

Biontech 4Q Net Pft EUR457.9M

DJ

Read

20 mar 2024, 10:15 UTC

Earnings

Biontech Plans For Ten or More Registrational Oncology Trials By End of 2024

DJ

Read

20 mar 2024, 10:15 UTC

Earnings

Biontech: Annemarie Hanekamp appointed to Management Board as Chief Commercial Officer, effective Jul. 1

DJ

Read

20 mar 2024, 10:15 UTC

Earnings

Biontech Aims For First Oncology Launch in 2026 and Ten Indication Approvals by 2030

DJ

Read

20 mar 2024, 10:15 UTC

Earnings

Biontech 2023 Gross Profit For COVID-19 Vaccine Business EUR3.2B

DJ

Read

20 mar 2024, 10:15 UTC

Earnings

Biontech Sees 2024 Revenue Between EUR2.5B - EUR3.1B

DJ

Read

20 mar 2024, 10:15 UTC

Earnings

Biontech 4Q Rev EUR1.48B

DJ

Read

8 lut 2024, 11:28 UTC

Acquisitions, Mergers, Takeovers

BioNTech Agrees To Invest $200 Mln in Autolus, Starts Strategic Collaboration

DJ

Read

Peer Comparison

Price change

BioNTech SE ADR Forecast

Price Target

By TipRanks

20.24% upside

12 Months Forecast

Average 108.4 USD  20.24%

High 171 USD

Low 85 USD

Based on 13 Wall Street analysts offering 12 month price targets forBioNTech SE ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

13 ratings

6

Buy

6

Hold

1

Sell

Based on 13 analysts giving stock ratings to BioNTech SE ADR - Dist in the past 3 months.

Technical Score

By Trading Central

88.19 / 90.24Support & Resistance

Short Term

Strong Bullish Evidence

All events are bullish.

Intermediate Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Long Term

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

114 / 365 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Other stocks from the sector

LLY

Eli Lilly and Co.

902.74

↓-0.9%

UNH

UnitedHealth Group Inc

596.8

↑ +0.31%

NVO

Novo Nordisk A-S

131.05

↑ +0.18%

JNJ

Johnson and Johnson

164.37

↓-0.29%

ABBV

AbbVie Inc

193.18

↑ +0.34%